Categories: UniversityWebsite
We develop precision medicines to modulate macrophages for the treatment of cancer, by bringing together world-leading cancer biologists.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.07.2021 | - | $5.92M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return t... | Annual #21toWatch announces shortlist in advance of return to in-person awards event
04-02-2022
Ne... | cambridgen... |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return t... | Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-b... | cambridgen... |
| 02.02.2022 | Investment in Scottish Scale-ups Doubled in 2021, New Figure... | Venture capital investment in Scottish scale-ups more than doubled last year, according to new figur... | digit.fyi/... |
| 05.08.2021 | The DIGIT Deal Roundup Column | July 2021 Edition | Investment and Funding Scottish National Investment Bank and Forev
The Scottish National Investment... | digit.fyi/... |
| 30.07.2021 | Macomics Raises £4.24M in Funding | Macomics, an Edinburgh, Scotland & Cambridge, UK-based immuno-oncology company, raised £4.24M in... | finsmes.co... |
| 29.07.2021 | Macomics, the Macrophage-based Drug Discovery company, secur... | Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announc... | marketscre... |
Reviews 0
